There are 2949 resources available
Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)
Presenter: Chrysalyne Schmults
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: Ana Oaknin
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Introduction
Presenter: Antonio González Martín
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Live Q&A - 24 September 2020 - 16:15-16:45
Presenter: Bradley Monk
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Live Q&A - 22 September 2020 - 16:15-16:45
Presenter: Sandra Swain
Session: F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Resources:
Webcast
Live Q&A - 23 September 2020 - 09:30-10:30
Presenter: Karim Fizazi
Session: F. Hoffmann-La Roche - Reshaping treatment paradigms for GU cancer patients: Perspectives on PI3K/AKT inhibitors in mCRPC and immunotherapy in urothelial cancer
Resources:
Webcast
Live Q&A - 28 September 2020 - 15:30-16:00
Presenter: Cristina Suarez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Introduction
Presenter: Giuseppe Curigliano
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
Introduction to RET mutations and fusions and their incidence for potential use as target in cancer treatment
Presenter: Alexander Drilon
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
RET fusion TKI: Present results and recent developments in Lung cancer
Presenter: David Planchard
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast